View Clinical Trial (Medical Research Study)

Study of Fibromyalgia Treated With Milnacipran - NCT01125423-12205(Clinical Trial 634216)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Albany
State:  
NY
Zip Code: 12205
Conditions: Fibromyalgia
Purpose: The purpose of this study is to examine the characteristics of the nerves and the small veins in the skin of people with fibromyalgia. This information will then be used to identify possible processes in the skin that may help explain why some people feel pain relief with the study drug (milnacipran) and others do not. The investigators expect to learn more about the pathophysiology of fibromyalgia and the way in which milnacipran acts on these patients. The investigators hypotheses are: 1. The pathophysiologic basis of fibromyalgia in some patients may be due to a biochemical and/or morphological pathology among the sensory innervation. 2. Fibromyalgia patients may have different sites of innervation. 3. Milnacipran may have a therapeutic effect on some fibromyalgia patients. 4. Abnormalities in fibromyalgia patients may predict the likelihood of a good response to milnacipran.
Study summary:
Criteria: Inclusion Criteria: - Female age 18-70 - fulfill the ACR criteria for FMA (wide spread pain for a least 3 months and pain in at least 11 or 18 tender point sites. - VAS score greater that 40mm at Screening and Randomization visits. Exclusion Criteria: - History of clinically significant liver disease, serious peripheral vascular disease, a blood clotting disorder, or any other medical condition felt to be exclusionary by the investigator. - Allergy to lidocaine - Unwillingness to sign informed consent or any other reasons for which the investigator feels the subject cannot complete the study - Women who are pregnant, breastfeeding or trying to become pregnant - Active cancer with the previous two years except treated basal cell carcinoma of the skin. - presence of dermatological or neurological condition that could interfere with the interpretation of the skin biopsy or QST - Co-existing conditions that can produce chronic widespread pain - Presence of uncontrolled or severe depression - Patients with Worker's Compensation, pending Worker's Compensation, - any ongoing litigation or disability claims due to fibromyalgia or any other source of pain, or currently receiving monetary compensation as a result of any of the above. - presence of uncontrolled narrow-angle glaucoma
Study is available at: Upstate Clinical Research, LLC
Albany, NY 12205
United States

Primary Contact:
Suzanne Alterman, RN
Email: salterman@upstateneuro.com
Phone: 518-533-1500

Secondary Contact:
Charles E. Argoff, MD
Email: czerwim@mail.amc.edu
Phone: 518 262 6538
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.